About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Review of Cardiovascular Therapy
›
Top Articles
Expert Review of Cardiovascular Therapy
Cardiology
2.5
(top 7%)
Impact Factor
2.8
(top 7%)
extended IF
54
(top 7%)
H-Index
1.3K
authors
2K
papers
24.2K
citations
3.8K
citing journals
20.2K
citing authors
Most Cited Articles of Expert Review of Cardiovascular Therapy
Title
Year
Citations
Neutrophil to lymphocyte ratio and cardiovascular diseases: a review
2013
372
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity
2008
340
Smoking and stroke: the more you smoke the more you stroke
2010
215
Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update
2016
172
Understanding the pathogenesis of abdominal aortic aneurysms
2015
171
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications
2008
171
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
2010
139
Biomaterial applications in cardiovascular tissue repair and regeneration
2012
122
The failing Fontan: etiology, diagnosis and management
2011
122
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease
2006
121
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability
2007
118
Reactive oxygen species in vascular biology: role in arterial hypertension
2003
117
Ezetimibe: cholesterol lowering and beyond
2008
107
Systematic review of reversible cerebral vasoconstriction syndrome
2010
102
Shear stress and plaque development
2010
99
Obesity and metabolic syndrome as related to cardiovascular disease
2012
96
HDL dysfunction in diabetes: causes and possible treatments
2012
92
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study)
2011
91
Symptomatic and asymptomatic carotid artery plaque
2011
89
Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease
2008
85
Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms
2010
81
Prevention of venous thromboembolism in obesity
2010
80
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
2006
79
Epidemiology of heart failure in sub-Saharan Africa
2009
76
Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia
2003
76
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.